LeMaitre Vascular (LMAT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 Apr, 2026Executive summary
The annual meeting is scheduled for June 2, 2026, with voting on director elections, executive compensation, and auditor ratification.
Proxy materials are distributed primarily online to reduce environmental impact and costs.
Shareholders can vote online, by phone, or by mail, and may attend the meeting in person with proper identification.
Voting matters and shareholder proposals
Shareholders will vote to elect two Class II directors for three-year terms, approve a non-binding advisory vote on 2025 executive compensation, and ratify Grant Thornton LLP as the independent auditor for 2026.
The board recommends voting FOR all proposals.
Shareholder proposals for the 2027 meeting must be received by December 18, 2026, with specific advance notice requirements.
Board of directors and corporate governance
The board will be reduced to seven members after the meeting, with a staggered three-class structure.
Five directors are deemed independent under Nasdaq standards.
The board is chaired by the CEO, with no lead independent director.
Committees include Audit, Compensation, and Nominating & Corporate Governance, all composed of independent directors.
The board has adopted a Code of Business Conduct and Ethics, Corporate Governance Guidelines, and a Director Resignation Policy.
Latest events from LeMaitre Vascular
- Votes will be held on director elections, executive pay, and auditor ratification at the June 2026 meeting.LMAT
Proxy filing14 Apr 2026 - Q4 2025 delivered strong growth and margins, with robust 2026 guidance and capital returns.LMAT
Q4 202513 Apr 2026 - Double-digit growth, global expansion, and 15 years of dividend increases drive strong outlook.LMAT
Investor presentation27 Feb 2026 - Q2 sales up 11%, net income up 46%, gross margin 68.9%, and 2024 guidance raised.LMAT
Q2 20242 Feb 2026 - Q3 2024 sales and EPS surged on pricing, biologics, and direct sales, with raised guidance.LMAT
Q3 202417 Jan 2026 - Double-digit growth, margin expansion, and higher shareholder returns drive 2025 outlook.LMAT
Q4 202423 Dec 2025 - Q1 2025 saw 13% organic sales growth, margin gains, and a raised outlook amid global expansion.LMAT
Q1 202523 Dec 2025 - Annual meeting to vote on directors, executive pay, say-on-pay frequency, and auditor ratification.LMAT
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, executive pay, and auditor at June 2025 annual meeting.LMAT
Proxy Filing1 Dec 2025